134 related articles for article (PubMed ID: 17875791)
21. Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin.
Saga T; Weinstein JN; Jeong JM; Heya T; Lee JT; Le N; Paik CH; Sung C; Neumann RD
Cancer Res; 1994 Apr; 54(8):2160-5. PubMed ID: 8174123
[TBL] [Abstract][Full Text] [Related]
22. Biological evaluation of avidin-based tumor pretargeting with DOTA-Triazole-Biotin constructed via versatile Cu(I) catalyzed click chemistry.
Uppal JK; Varshney R; Hazari PP; Chuttani K; Kaushik NK; Mishra AK
J Drug Target; 2011 Jul; 19(6):418-26. PubMed ID: 20678008
[TBL] [Abstract][Full Text] [Related]
23. Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein.
Sato N; Hassan R; Axworthy DB; Wong KJ; Yu S; Theodore LJ; Lin Y; Park L; Brechbiel MW; Pastan I; Paik CH; Carrasquillo JA
J Nucl Med; 2005 Jul; 46(7):1201-9. PubMed ID: 16000290
[TBL] [Abstract][Full Text] [Related]
24. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
[TBL] [Abstract][Full Text] [Related]
25. Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.
McBride WJ; Zanzonico P; Sharkey RM; Norén C; Karacay H; Rossi EA; Losman MJ; Brard PY; Chang CH; Larson SM; Goldenberg DM
J Nucl Med; 2006 Oct; 47(10):1678-88. PubMed ID: 17015905
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of a DOTA-lysine-biotin conjugate as an effector molecule for pretargeted radionuclide therapy.
Hainsworth J; Harrison P; Mather SJ
Bioconjug Chem; 2005; 16(6):1468-74. PubMed ID: 16287243
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and biodistribution of [111In]-avidin and [99mTc]-biotin-liposomes injected in the pleural space for the targeting of mediastinal nodes.
Medina LA; Klipper R; Phillips WT; Goins B
Nucl Med Biol; 2004 Jan; 31(1):41-51. PubMed ID: 14741569
[TBL] [Abstract][Full Text] [Related]
28. Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies.
Shen S; Forero A; LoBuglio AF; Breitz H; Khazaeli MB; Fisher DR; Wang W; Meredith RF
J Nucl Med; 2005 Apr; 46(4):642-51. PubMed ID: 15809487
[TBL] [Abstract][Full Text] [Related]
29. Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targeting.
Chinol M; Paganelli G; Sudati F; Meares C; Fazio F
Nucl Med Commun; 1997 Feb; 18(2):176-82. PubMed ID: 9076775
[TBL] [Abstract][Full Text] [Related]
30. Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody.
Hnatowich DJ; Fritz B; Virzi F; Mardirossian G; Rusckowski M
Nucl Med Biol; 1993 Feb; 20(2):189-95. PubMed ID: 8448574
[TBL] [Abstract][Full Text] [Related]
31. Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.
Lewis MR; Zhang J; Jia F; Owen NK; Cutler CS; Embree MF; Schultz J; Theodore LJ; Ketring AR; Jurisson SS; Axworthy DB
Nucl Med Biol; 2004 Feb; 31(2):213-23. PubMed ID: 15013487
[TBL] [Abstract][Full Text] [Related]
32. Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer.
Paganelli G; Ferrari M; Ravasi L; Cremonesi M; De Cicco C; Galimberti V; Sivolapenko G; Luini A; De Santis R; Travaini LL; Fiorenza M; Chinol M; Papi S; Zanna C; Carminati P; Veronesi U
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5646s-5651s. PubMed ID: 17875802
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.
Nemecek ER; Green DJ; Fisher DR; Pagel JM; Lin Y; Gopal AK; Durack LD; Rajendran JG; Wilbur DS; Nilsson R; Sandberg B; Press OW
Cancer Biother Radiopharm; 2008 Apr; 23(2):181-91. PubMed ID: 18454687
[TBL] [Abstract][Full Text] [Related]
34. Potential of three-step pretargeting radioimmunotherapy using biotinylated bevacizumab and succinylated streptavidin in triple-negative breast cancer xenograft.
Gu W; Yudistiro R; Hanaoka H; Katsumata N; Tsushima Y
Ann Nucl Med; 2021 Apr; 35(4):514-522. PubMed ID: 33582981
[TBL] [Abstract][Full Text] [Related]
35. Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication.
Kalofonos HP; Rusckowski M; Siebecker DA; Sivolapenko GB; Snook D; Lavender JP; Epenetos AA; Hnatowich DJ
J Nucl Med; 1990 Nov; 31(11):1791-6. PubMed ID: 2230992
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 125I- and (111)In-labeled monoclonal antibody BR96 for tumor targeting in combination with extracorporeal immunoadsorption.
Garkavij M; Tennvall J; Ohlsson T; Lindgren L; Hindorf C; Sjögren HO; Strand SE
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3059s-3064s. PubMed ID: 10541344
[TBL] [Abstract][Full Text] [Related]
37. Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results.
Weiden PL; Breitz HB; Press O; Appelbaum JW; Bryan JK; Gaffigan S; Stone D; Axworthy D; Fisher D; Reno J
Cancer Biother Radiopharm; 2000 Feb; 15(1):15-29. PubMed ID: 10740649
[TBL] [Abstract][Full Text] [Related]
38. Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodies.
Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Nilsson R; Sandberg BE; Brechbiel M
Bioconjug Chem; 2002; 13(5):1079-92. PubMed ID: 12236790
[TBL] [Abstract][Full Text] [Related]
39. Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody.
Zhang M; Sakahara H; Yao Z; Saga T; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
Nucl Med Biol; 1997 Jan; 24(1):61-4. PubMed ID: 9080476
[TBL] [Abstract][Full Text] [Related]
40. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
He J; Liu G; Gupta S; Zhang Y; Rusckowski M; Hnatowich DJ
J Nucl Med; 2004 Jun; 45(6):1087-95. PubMed ID: 15181145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
